RAILY AESMED (02135.HK) issued a profit warning, expecting a loss of approximately 8 million RMB for the six months ending in June, compared to a profit of 2 million RMB in the same period last year. The loss is mainly attributed to a decrease in total revenue of 32 million RMB; stock option expenses of approximately 1 million RMB; and management and R&D expenses of approximately 1 million RMB for its subsidiary Suzhou Ruichuan
"Profit Warning" RAILY AESMED estimates mid-term losses to expand to 8 million RMB
LongbridgeAI
